Overall rank by patents
#2,647
Across all tracked assignees
USPTO PatentsView assignee record - 147 granted patents across 20 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).
The verdict
Medtronic holds 147 US patents across 20 technology areas, rank #2,647 of 50,000 tracked assignees.
Medtronic Cryocath Lp has been granted 147 US utility patents between 2015 and 2025, placing Medtronic Cryocath Lp at rank #2,647 across all assignees tracked by PlainPatent. This portfolio spans 20 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.1 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, Medtronic Cryocath Lp is one of the more focused assignees in the PatentsView dataset. By volume, Medtronic sits between Interface Technology (chengdu) Co., Ltd. (147 patents, rank #2,643) and Apollo Intelligent Driving Technology (beijing) Co., Ltd. (146 patents, rank #2,651) - the closest US assignees by grant volume. The composite Innovation Score of 47.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 60 grants, compared with 87 in the 2015–2019 window, a -31% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Medtronic Cryocath Lp's 15.1 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 20 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Medtronic Cryocath Lp against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Interface Technology (ChengDu) Co., Ltd.
147 patents
Intex Marketing Ltd.
147 patents
James R. Glidewell Dental Ceramics, Inc.
147 patents
Lotte Chemical Corporation
147 patents
QUEST SOFTWARE INC.
147 patents
Sage Products, LLC
147 patents
Unison Industries, LLC
147 patents
Medtronic CryoCath LP
147 patents
APOLLO INTELLIGENT DRIVING TECHNOLOGY (BEIJING) CO., LTD.
146 patents
What this shows Medtronic holds 147 patents at rank #2,647, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #2,647 in granted patent volume.
Other assignees with the most granted patents in Medtronic's primary technology class.
Medtronic's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
48 Top 18% higher than 82% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 16 | 10.9% |
| 2016 | 14 | 9.5% |
| 2017 | 18 | 12.2% |
| 2018 | 23 | 15.6% |
| 2019 | 16 | 10.9% |
| 2020 | 9 | 6.1% |
| 2021 | 13 | 8.8% |
| 2022 | 7 | 4.8% |
| 2023 | 13 | 8.8% |
| 2024 | 12 | 8.2% |
| 2025 | 6 | 4.1% |
Top 15 of 20 technology areas
Overall rank by patents
#2,647
Across all tracked assignees
47.8 out of 100
How to use this portfolio
Medtronic's 147 grants land it in the top 18% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.